1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Valneva SE
  6. News
  7. Summary
    VLA   FR0004056851

VALNEVA SE

(VLA)
  Report
Real-time Euronext Paris  -  05/27 11:35:17 am EDT
11.42 EUR   +3.16%
05/26VALNEVA : Successfully Completes Lot-to-Lot Consistency Trial for its Single-Shot Chikungunya Vaccine Candidate - Form 6-K
PU
05/25VALNEVA : KOL Presentation on the Chikungunya Virus
PU
05/25Valneva's Chikungunya Vaccine Candidate Triggers Equal Immune Responses in Lot-to-Lot Late-Stage Study
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Valneva Starts Extended Trial to Study Booster Shot of COVID-19 Vaccine; Shares Up 9%

01/25/2022 | 02:02pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 0.40% 10588 Delayed Quote.21.92%
VALNEVA SE 3.16% 11.415 Real-time Quote.-53.41%
All news about VALNEVA SE
05/26VALNEVA : Successfully Completes Lot-to-Lot Consistency Trial for its Single-Shot Chikungu..
PU
05/25VALNEVA : KOL Presentation on the Chikungunya Virus
PU
05/25Valneva's Chikungunya Vaccine Candidate Triggers Equal Immune Responses in Lot-to-Lot L..
MT
05/25Valneva Successfully Completes Lot-to-Lot Consistency Trial for its Single-Shot Chikung..
GL
05/25Valneva Successfully Completes Lot-to-Lot Consistency Trial for its Single-Shot Chikung..
AQ
05/25Valneva Successfully Completes Lot-To-Lot Consistency Trial for Its Single-Shot Chikung..
CI
05/20VALNEVA : EMA Accepts Filing of Marketing Authorization Application for Valneva's Inactiva..
PU
05/20EMA Accepts Filing of Marketing Authorization Application for Valneva's Inactivated COV..
CI
05/20EMA accepts filing of marketing authorization application for Valneva's inactivated COV..
AQ
05/19European shares lower as retailers, food and beverage stocks lead falls
RE
More news
Analyst Recommendations on VALNEVA SE
More recommendations
Financials
Sales 2022 343 M 367 M 367 M
Net income 2022 -28,5 M -30,6 M -30,6 M
Net cash 2022 213 M 228 M 228 M
P/E ratio 2022 -33,6x
Yield 2022 -
Capitalization 1 230 M 1 318 M 1 318 M
EV / Sales 2022 2,97x
EV / Sales 2023 1,28x
Nbr of Employees 762
Free-Float 73,9%
Chart VALNEVA SE
Duration : Period :
Valneva SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VALNEVA SE
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 11,42 €
Average target price 20,08 €
Spread / Average Target 75,9%
EPS Revisions
Managers and Directors
Thomas Lingelbach President & Chief Executive Officer
Franck Charles Marie Grimaud Director General & Chief Business Officer
Peter Buhler Chief Financial Officer & Director
Frédéric Grimaud Chairman-Supervisory Board
Michael Möhlen Vice President-Technical Development
Sector and Competitors
1st jan.Capi. (M$)
VALNEVA SE-53.41%1 318
MODERNA, INC.-41.86%54 016
LONZA GROUP AG-28.07%42 292
IQVIA HOLDINGS INC.-21.85%39 319
SEAGEN INC.-8.54%25 487
ICON PUBLIC LIMITED COMPANY-26.61%17 693